Adherium reports strong patient adoption and new US partnerships, positioning for significant expansion in 2025 with a target of 9,000 active users and entry into the Pharmacy Benefit Management sector.
Ada Torres
31 Jan 2025
Subscribe to Updates
Get moves for Adherium (ASX:ADR) direct to your inbox.
You're on the list!
We'll ping you the moment Adherium (ASX:ADR) makes a move.
Until then, follow us on socials.
Join 1000's of market focused, signal seeking investors. Unsubscribe anytime. We don't sell your data.